Point Of Contact Not Available

Assay Services for Protein Biomarkers of Alzheimer’s Disease & Neurodegeneration The University of Wisconsin-Madison is requesting a sole source waiver for over $25K with Quanterix Corporation, a private, for profit, company. The purchase is for assay services for protein biomarkers of Alzheimer’s disease and neurodegeneration. Samples from study participants will be assayed using Quanterix’s proprietary technology. Services will start in December 2020. The cost of the services over a 12 month term will be $563,540. For more information contact: Janet Bresnahan (608)262-6335 [email protected] Related Links: Attachments:

Bid Protests Not Available